Evidence map›Paper›PMID 42695703›Full record

ArticleProceedings (Baylor University. Medical Center)2026

Impact of bariatric surgery on cardiovascular and cerebrovascular outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide analysis.

Omar Alkasabrah, Mohamed ElZayat, Muhammad Qasim Chaudhry, Mohamed H Eldesouki, Sameeha Ibrahim, Abdullah Serhan, Tanuj Sharma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Omar AlkasabrahDepartment of Internal Medicine, New York Medical College at Landmark Medical Center, Woonsocket, Rhode Island, USA.ORCID 0009-0000-9767-7226
Mohamed ElZayatDepartment of Internal Medicine, Alexandria Main University Hospital, Alexandria, Egypt.
Muhammad Qasim ChaudhryDepartment of Internal Medicine, New York Medical College at Landmark Medical Center, Woonsocket, Rhode Island, USA.
Mohamed H EldesoukiDepartment of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA.
Sameeha IbrahimFaculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.
Abdullah SerhanEpilepsy Center Neurological Institute, University Hospitals, Cleveland Medical Center, Cleveland, Ohio, USA.
Tanuj SharmaDepartment of Gastroenterology and Hepatology, New York Medical College at Landmark Medical Center, Woonsocket, Rhode Island, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise, with strong associations with obesity and cardiometabolic diseases. Bariatric surgery (BS) has shown metabolic benefits in MASLD, but its impact on major adverse cardiovascular and cerebrovascular events (MACCE) remains unclear.

methodsNational Inpatient Sample data from 2016 to 2022 were used to identify adults aged ≥18 years with hepatic steatosis or steatohepatitis and at least one metabolic risk factor, approximating established MASLD criteria. Patients were then stratified by prior BS status, and multivariable logistic regression was used to assess the outcomes after adjustment for potential confounders. Outcomes were reported as adjusted odds ratios (aOR) with 95% confidence intervals (CI).

resultsAmong 3,668,314 MASLD patients, 394,535 underwent BS. BS was associated with lower odds of all-cause mortality (aOR 0.33, 95% CI 0.32-0.34), myocardial infarction (aOR 0.38, 95% CI 0.36-0.39), stroke (aOR 0.87, 95% CI 0.86-0.88), atrial fibrillation (aOR 0.73, 95% CI 0.72-0.74), and heart failure (aOR 0.52, 95% CI 0.52-0.57); all

conclusionBS was associated with lower risk of MACCE, mortality, and resource utilization in patients with MASLD, supporting its beneficial role.

Indexed as

Bariatric SurgeryCardiovascular DiseasesCerebrovascular DisordersFatty LiverAdultFemaleHumansMaleMiddle AgedObesityRisk FactorsUnited StatesBariatric surgerycardiovascular outcomescerebrovascular outcomesmetabolic dysfunction–associated steatotic liver diseaseNational Inpatient Sample

Identifiers

PMID42695703
PMCPMC13689784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.